Small Molecule Drug Discovery Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The Small Molecule Drug Discovery Market was valued at approximately USD 32,150 million in 2020, and it is expected to reach 51,160 million by 2027, registering a CAGR of nearly 8% during the forecast period, 2021-2027.

Small molecule drugs are used for targeted drug delivery, in which small molecules cross the cell membrane and act on specific organelles or proteins. Because of their low molecular weight, low-molecular drugs can easily enter cells. These molecules outperform monoclonal antibodies and other large molecule drugs due to their size, easy conversion to oral form, and cost effectiveness. The small molecule drug discovery market is expected to witness tremendous growth owing to increasing approval of small molecule drugs, increasing demand for R&D by contract organizations, and increasing adoption of small molecules in the treatment of chronic diseases. However, high drug development costs are expected to restrain the growth of the market during the forecast period.

Market Segments

By Therapeutic Area

• Oncology
• Central Nervous System
• Cardiovascular
• Respiratory
• Orthopedics
• Immunology
• Rare Diseases
• Other Therapeutic Areas

By Process/Phase

• Target Discovery
• Target Validation
• Lead Generation and Refinement
• Preclinical Development

Key Players

• Johnson and Johnson Services, Inc.
• Teva Pharmaceutical Industries Ltd
• Boehringer Ingelheim International GmbH
• Allergan Plc.
• Pfizer Inc.
• Bristol-Myers Squibb Company
• MERCK KGaA
• GlaxoSmithKline plc.

Scope of the Report

The research study analyzes the global Small Molecule Drug Discovery industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Small Molecule Drug Discovery Market Report

1. What was the Small Molecule Drug Discovery Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Small Molecule Drug Discovery Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Small Molecule Drug Discovery Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.